Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases
Decades of work on RNA targeting, chemical modification, and tissue-specific delivery are reshaping what programmable genetic medicines can…
Weill Cornell Medicine receives federal grant to study new gene therapy for Alzheimer’s disease
The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth…
Simple blood test maps hidden Alzheimer’s disease changes
A large community study shows that Alzheimer’s-related brain changes are far more widespread with age than symptoms alone…